Bicara Therapeutics Inc. (BCAX) Free cash flow 2023–2025
Bicara Therapeutics Inc. (BCAX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$107.1MFY2025 · since FY2023: -$46.2M → -$107.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$107.1M | -43.2% |
| FY2024 | -$74.8M | -61.9% |
| FY2023 | -$46.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice